Nicholas Conor Institute Corporation

Our Mission isto meet pediatric cancer head on with superior detection methods anddiagnostic tools coupled with kid friendly treatments that bring hopeto all those involved: By translating biomedical discoveries into integrated, personalized treatment programs By developing cancer-specific predictive teststo guide cancer therapy for each child By bringing to the clinic new therapies that consider the unique molecular physiology of each child and his or her cancer.The Nicholas Conor Institute was founded to acceleratelaboratory discoveries into integrated, individualized treatmentprograms for children with cancer. Pediatric patients with cancer needregimens that will reduce unnecessary exposure to toxic drugs andminimize long-term side effects, while resulting in better responsesand longer survival.Institute staff will collaborate closely with oncologists to matchdiagnostic evaluations with customized therapies specific to eachchild. This personalized approach differs markedly from currenttreatments, in that it uses molecular guidance in addition totraditional staging-based diagnosis to effectively treat children withcancer.Through collaborations with biomedical research institutions, hospitalsand the biotechnology industry,  The Nicholas Conor Institute willbridge gaps between academia and applied clinical practice to benefitchildren with cancer.